Carolina Ribeiro

Mrs. Carolina Ribeiro


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
KLKELY LIMA
KELY LIMA
RGRafaelli de Souza Gomes
Rafaelli de Souza Gomes
PPPriscilla Pereira
Priscilla Pereira
PCPaula Giselle Czaikoski
Paula Giselle Czaikoski
CRCarolina Ribeiro
Carolina Ribeiro
MMMarta Monteiro
Marta Monteiro
Macrophages and neutrophils are key components involved in the regulation of numerous chronic inflammatory diseases, infectious disorders, and especially certain autoimmune disease. However, little is known regarding the contribution of these cells to the pathogenesis of autoimmune disorders. Recent studies have aimed to clarify certain important factors affecting the immunogenicity of these cells, including the type and dose of antigen, the microenvironment of the cell-antigen encounter, and the number, subset, and phenotype of these cells, which can prevent or induce autoimmune responses. This review highlights the role of macrophage subsets and neutrophils in injured tissues, supporting their cooperation during the pathogenesis of certain autoimmune diseases.

5 November 2022 in Toxins
Verified
Journal Article
Open access
PDF file
JEJorge Eduardo Chang Estrada
Jorge Eduardo Chang Estrada
KRKeuri Eleutério Rodrigues
Keuri Eleutério Rodrigues
ALAnderson Maciel de Lima
Anderson Maciel de Lima
CBCahy Manoel Bannwart
Cahy Manoel Bannwart
WDWictória Farias Dias
Wictória Farias Dias
Alejandro Ferraz PradoAlejandro Ferraz Prado
Alejandro Ferraz Prado
BmooMPα-I has kininogenase activity, cleaving kininogen releasing bradykinin and can hydrolyze angiotensin I at post-proline and aspartic acid positions, generating an inactive peptide. We evaluated the antihypertensive activity of BmooMPα-I in a model of two-kidney, one-clip (2K1C). Wistar rats were divided into groups: Sham, who underwent sham surgery, and 2K1C, who suffered stenosis of the right renal artery. In the second week of hypertension, we started treatment (Vehicle, BmooMPα-I and Losartan) for two weeks. We performed an electrocardiogram and blood and heart collection in the fourth week of hypertension. The 2K1C BmooMPα-I showed a reduction in blood pressure (systolic pressure: 131 ± 2 mmHg; diastolic pressure: 84 ± 2 mmHg versus 174 ± 3 mmHg; 97 ± 4 mmHg, 2K1C Vehicle, p < 0.05), improvement in electrocardiographic parameters (Heart Rate: 297 ± 4 bpm; QRS: 42 ± 0.1 ms; QT: 92 ± 1 ms versus 332 ± 6 bpm; 48 ± 0.2 ms; 122 ± 1 ms, 2K1C Vehicle, p < 0.05), without changing the hematological profile (platelets: 758 ± 67; leukocytes: 3980 ± 326 versus 758 ± 75; 4400 ± 800, 2K1C Vehicle, p > 0.05), with reversal of hypertrophy (left ventricular area: 12.1 ± 0.3; left ventricle wall thickness: 2.5 ± 0.2; septum wall thickness: 2.3 ± 0.06 versus 10.5 ± 0.3; 2.7 ± 0.2; 2.5 ± 0.04, 2K1C Vehicle, p < 0.05) and fibrosis (3.9 ± 0.2 versus 7.4 ± 0.7, 2K1C Vehicle, p < 0.05). We concluded that BmooMPα-I improved blood pressure levels and cardiac remodeling, having a cardioprotective effect.

8 October 2026 in Diabetology
Verified
Journal Article
Open access
PDF file
AOAlana Ferreira de Oliveira
Alana Ferreira de Oliveira
LALaila de Castro Araújo
Laila de Castro Araújo
TOTatiana CRISTINA DIAS Oliveira
Tatiana CRISTINA DIAS Oliveira
VFValéria de Castro Fagundes
Valéria de Castro Fagundes
LRLorena dos Reis Rabelo
Lorena dos Reis Rabelo
LSLuann Wendel Pereira de Sena
Luann Wendel Pereira de Sena
Objective: Obesity and type 2 diabetes mellitus frequently coexist and require therapeutic strategies capable of addressing both excess adiposity and cardiometabolic risk. However, real-world evidence on whether improvements in cardiometabolic parameters are accompanied by clinically meaningful weight loss remains limited, particularly in public healthcare settings in the Brazilian Amazon. This study evaluated longitudinal changes in body weight and cardiometabolic parameters among adults with obesity receiving routine outpatient endocrinology care within the Brazilian Unified Health System and investigated the relationship between weight change, glycemic response, and factors associated with therapeutic target achievement. As a complementary metabolic analysis, longitudinal changes in the triglyceride–glucose (TyG) index, as a surrogate marker of insulin resistance, were also evaluated. Methods: This retrospective longitudinal observational study included 90 adults with obesity receiving routine outpatient endocrinology care within the Brazilian Unified Health System in Marabá, Pará, Brazil. Participants had at least six months of follow-up, with a mean follow-up duration of 14.3 ± 4.0 months. Changes in anthropometric, glycemic, blood pressure, and lipid parameters were evaluated between baseline and follow-up. The TyG index was calculated from fasting plasma glucose and triglyceride concentrations, with longitudinal TyG analysis restricted to participants with paired measurements available at baseline and follow-up. Standardized within-participant effect sizes were estimated using Cohen’s dz with bootstrap 95% confidence intervals (CIs). Spearman correlations were used to examine associations between percentage weight change and cardiometabolic changes. Multivariable logistic regression models evaluated factors associated with achieving HbA1c < 7.0% among participants with type 2 diabetes mellitus and ≥5% weight loss in the overall cohort. Results: Body weight changed minimally during follow-up (mean Δ = −0.47 kg; dz = −0.072; 95% CI −0.306 to 0.126), whereas HbA1c decreased by 1.00 percentage point (dz = −0.441; 95% CI −0.751 to −0.219). Small reductions were also observed in fasting plasma glucose (Δ = −31.53 mg/dL), LDL cholesterol (Δ = −15.79 mg/dL), and triglycerides (Δ = −35.30 mg/dL). Among 51 participants with complete paired fasting plasma glucose and triglyceride measurements, mean TyG decreased from 9.68 ± 0.85 to 9.29 ± 0.79 (mean Δ = −0.39; 95% CI −0.58 to −0.20; p < 0.001), with a moderate standardized within-participant effect (dz = −0.569; bootstrap 95% CI −0.881 to −0.301). Only 21/90 participants (23.3%) achieved ≥5% weight loss, while 44/90 (48.9%) gained weight. Among participants with paired HbA1c measurements, the proportion with HbA1c ≥7.0% decreased from 72.9% to 52.9%. Percentage weight change was not significantly correlated with changes in HbA1c (rs = −0.018; p = 0.882), fasting plasma glucose, or lipid parameters, nor with change in TyG (rs = −0.041; p = 0.776). Self-reported medication adherence was associated with a greater median reduction in HbA1c (−1.55 vs. 0.00 percentage points; p = 0.003) and higher adjusted odds of achieving HbA1c < 7.0% (OR = 3.58; 95% CI 1.08–11.86; p = 0.037) but was not associated with weight-loss response. No evaluated baseline characteristic was significantly associated with achieving ≥5% weight loss. Conclusions: In adults with obesity receiving routine outpatient endocrinology care within the Brazilian Unified Health System in the Brazilian Amazon, longitudinal follow-up was accompanied by modest improvements in glycemic and selected lipid parameters but minimal average weight reduction. The TyG index also decreased significantly among participants with paired measurements, consistent with improvement in this surrogate marker of insulin resistance; however, this finding should not be interpreted as direct evidence of improved insulin sensitivity or reduced cardiovascular risk. Clinically meaningful weight loss was achieved by fewer than one quarter of participants, and nearly half gained weight. Medication adherence was associated with better glycemic control but not with weight loss. These findings indicate that improvements in conventional and surrogate metabolic markers were not consistently accompanied by meaningful reductions in body weight and support the incorporation of weight-specific outcomes and comprehensive obesity-directed strategies into chronic disease care.

3 February 2025 in Caderno Pedagógico
Verified
Journal Article
Open access
PDF file
RSRodrigo Texeira Santiago
Rodrigo Texeira Santiago
OSOrenzio Soler
Orenzio Soler
APAna Cristina Lo Prete
Ana Cristina Lo Prete
CRCarolina Ribeiro
Carolina Ribeiro
Objetivo: Mapear as evidências sobre o uso de protocolos de acompanhamento farmacoterapêutico em pacientes em uso de anticoagulantes internados em Unidades de Terapia Intensiva (UTIs). Metodologia: Trata-se de uma Revisão de Escopo. Utilizou-se o Prisma-ScR com base no acrônimo PCC; onde Participantes (P) = Pacientes internados em uso de anticoagulantes; Conceito (C) = Protocolo farmacoterapêutico; Contexto (C) = Unidade de terapia intensiva. Resultados: Indicam que os protocolos contribuem para a melhora na gestão da terapia antitrombótica, redução de complicações como eventos hemorrágicos e otimização de doses. Conclusão: Infere-se que a utilização de protocolos de acompanhamento farmacoterapêutico em pacientes em uso de anticoagulantes em Unidades de Terapia Intensiva (UTI) demonstra benefícios quanto aos desfechos clínicos; entretanto, há lacunas quanto aos desfechos humanísticos e econômicos.

5 October 2023 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
RMRenato Bruno Cavalcante de Melo
Renato Bruno Cavalcante de Melo
MSMaria Pantoja Moreira de Sena
Maria Pantoja Moreira de Sena
COCamila Martins Oliveira
Camila Martins Oliveira
MSMarcos Felipe Rodrigues de Souza
Marcos Felipe Rodrigues de Souza
CSClarisse Andrade Sales
Clarisse Andrade Sales
LSLuann Wendel Pereira de Sena
Luann Wendel Pereira de Sena
Background: Immunochromatographic rapid tests in pharmacies allow the discovery of specific antibodies against SARS-CoV-2 or viral antigens and provide a broader and more effective screening of the virus. However, in many countries, this process is still not well defined. In this sense, the perception of pharmacists about these screening practices presents an overview of how the service is being carried out in the country. Objective: This study was to evaluate the performance of rapid immunochromatographic tests and their clinical results in community pharmacies in northern Brazil. Method: A retrospective study was carried out between May 2020 and December 2021 in community pharmacies in the northern region of Brazil. Participants were 18 years of age or older, of both sexes, who spontaneously sought the SARS-CoV-2 rapid testing service at pharmacies located in the municipality of Belem and who had had close contact with the virus or symptoms infection-related. Data were expressed as median and range or as frequency of occurrence. Chi-square t-test and Fisher’s exact test were used to compare variables. The accepted significance level was 5%. This study was approved by the Research Ethics Committee (number: 4,865,206). Results: A total of 78,849 patients were recruited into the study. Most patients, 37,847 (48%), were tested antibody positive for SARS-CoV-2. There were no severe signs and symptoms of the disease. The results showed the great demand for carrying out the rapid test in pharmacies and these places could contribute to the understanding of this health establishment, to curb the speed of SARS-CoV-2 dissemination. Conclusion: This study showed the demand for rapid tests for SARS-CoV-2 in pharmacies, as well as the large number of patients identified with the disease. Thus, these places must exercise a workforce and obtain organized actions to collaborate with the rest of the health system, reducing the overload of urgent and emergency units, as well as the risk of contamination that seek them

20 September 2026 in Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
ÚAÚrsula Ghassan El Awar
Úrsula Ghassan El Awar
LALara Ghassan El Awar
Lara Ghassan El Awar
PMPietro Chaves Amaral Miralha
Pietro Chaves Amaral Miralha
FFFrancisco Jordano da Silva Feitosa
Francisco Jordano da Silva Feitosa
KCKarimy Moreira Cavalcante
Karimy Moreira Cavalcante
LSLuann Wendel Pereira de Sena
Luann Wendel Pereira de Sena
Background/Objectives: Social media has become a major source of health information worldwide; however, how users appraise the credibility of online health information and verify its reliability may be associated with medication-related decision-making. This study examined the associations of perceived credibility of health information encountered on social media and information-verification behavior with self-medication among adult social media users. As a secondary exploratory objective, we examined self-reported negative perceived effects following health-related decisions influenced by social media information. Methods: A cross-sectional online survey was conducted between August 2025 and February 2026 among 1935 adult social media users. Data were collected using a structured questionnaire assessing sociodemographic characteristics, perceived credibility, information-verification behavior, health-related decisions influenced by social media, and reported perceived effects. Descriptive and bivariate analyses and multivariable logistic regression models were performed, with penalized logistic regression used as a sensitivity analysis. Results: Healthcare professionals (59.9%) and the citation of reliable sources (44.1%) were the characteristics most frequently associated with perceived credibility. Although participants generally reported moderate perceived credibility of health information encountered on social media, 54.9% reported inconsistent information-verification practices. High perceived credibility was associated with higher odds of inconsistent information-verification behavior compared with low or moderate perceived credibility (OR = 2.77; 95% CI: 2.26–3.38; p < 0.001). Self-medication influenced by social media information was reported by 32.2% of participants. After multivariable adjustment, inconsistent information-verification behavior showed the strongest association with self-medication (aOR = 14.80; 95% CI: 10.07–21.73; p < 0.001). Participants reporting low or moderate perceived credibility had lower odds of self-medication than those reporting high perceived credibility (aOR = 0.36; 95% CI: 0.26–0.49; p < 0.001). Secondary exploratory analyses restricted to participants reporting a social media-influenced health decision (n = 1556) also identified associations between reported negative perceived effects, self-medication, and information-verification behavior. These findings should be interpreted cautiously because of the retrospective self-report and sequential structure of the questionnaire items. Conclusions: Overall, perceived credibility and information-verification behavior emerged as related, but distinct dimensions of digital health-information appraisal associated with medication-related decision-making. These findings highlight the importance of digital health literacy strategies that promote critical appraisal and systematic verification of online health information before it is incorporated into medication-related decisions.